450 MHz LTE: Stronger, Smarter Grid for Brazil
BELO HORIZONTE, Brazil, May 7, 2026 /PRNewswire/ -- Every day, millions of Brazilians press a button. They turn on a computer. They start a production machine. And energy simply happens. But what lies behind that button has become infinitely more...
2026 ASCO Preview | Results from Phase III Study of Anbenitamab (KN026) Combined with HB1801 in Neoadjuvant Treatment for Breast Cancer Selected for LBA Oral Presentation
SUZHOU, China, April 22, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the significant results from the Phase III clinical study (KN026-004) of HER2 bispecific antibody Anbenitamab Injection (KN026), independently...
HCLTech FY26 revenue up 3.9%, led by increasing demand for Advanced AI
Annualized Advanced AI revenue at $620M; FY26 services revenue up 4.8% in CC; TCV of new deal wins at $9.3B NEW YORK and NOIDA, India, April 22, 2026 /PRNewswire/ -- HCLTech, a leading global technology company, today reported financial results for...
Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development
-Fixed - dose combination of ASC30 and ASC39 (ASC30_39 FDC) tablets, dosed orally in dogs, demonstrated comparable pharmacokinetics to those observed in their respective monotherapies in a head-to-head study . The fixed dose combination had...
DNV SELECTED TO CERTIFY CLASS D DEVICES FOR LEADING U.S. MANUFACTURER UNDER EU IVDR
DNV supports the manufacturer's transition to new regulation with its digital certification platform and transparent, predictable project management. OSLO, Norway, March 31, 2026 /PRNewswire/ -- DNV, a designated Notified Body for the European...
Oral Small Molecule Amylin Receptor Agonist ASC39 Demonstrated Eloralintide-like Amylin Selectivity and Efficacy in Preclinical Models
- In a head-to-head cyclic adenosine monophosphate (cAMP) activation assay vs. eloralintide, oral small molecule amylin receptor agonist ASC39 demonstrated similar selectivity and potency to that of eloralintide. EC 50 for human amylin 1 receptor...
Tejas Networks selected for a 4G network expansion project in South Asia
BENGALURU, India, March 16, 2026 /PRNewswire/ -- Tejas Networks (BSE: 540595) (NSE: TEJASNET) today announced that the company has received a purchase order to supply its state-of-the-art 4G RAN (Radio Access Network) solutions for a mobile network...
BIEL Crystal selected as exclusive supplier of cover glass for iPhone 17e
HONG KONG, March 9, 2026 /PRNewswire/ -- Apple's latest budget-friendly smartphone, the iPhone 17e, makes its debut featuring significant storage upgrades and the same trusted durability. Retailing at a starting price of $599, the device now offers...
AION V garners global honors, underscoring China's rising strength in smart EV innovation.
GUANGZHOU, China, March 5, 2026 /PRNewswire/ -- In 2025, GAC AION V is garnering remarkable international acclaim across global markets, securing a series of prestigious awards and top safety ratings that underscore its competitive prowess as a...
Brandwatch and Blackbird.AI Consortium Selected by NATO to Deliver Information Environment Assessment Capability
AI-enabled capability will support NATO with insight across complex information environments BRIGHTON, United Kingdom, Feb. 10, 2026 /PRNewswire/ -- Brandwatch, a Cision company and a global leader in social intelligence and social media management,...